Patient Navigator for Hereditary Diseases

Phase-Based Progress Estimates
Hereditary Diseases+29 More
Patient Navigator - Other
< 65
All Sexes
What conditions do you have?

Study Summary

This trial will help guide how best to provide care for adolescents with chronic health conditions as they transition to adulthood.

Eligible Conditions
  • Hereditary Diseases
  • Autism Spectrum Disorders
  • Kidney Diseases
  • Hematologic Diseases
  • Endocrine System Diseases
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Diabetes
  • Aura
  • Cardiac Diseases
  • Gastrointestinal Disorder
  • Fetal Alcohol Syndrome
  • Autism Spectrum Disorder
  • Neurodegenerative Disorders
  • Autoimmune Diseases
  • Metabolic Diseases
  • Respiratory Diseases

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Hereditary Diseases

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 12 to 24 months

12 to 24 months
Health services utilization
Month 24
Variation in SF-12 Scores
Variation in TRAQ (Transition Readiness Questionnaire) scores
Month 24
Youth/Caregiver Satisfaction
up to 24 months
cost analysis

Trial Safety

Safety Progress

1 of 3

Other trials for Hereditary Diseases

Trial Design

1 Treatment Group

Patient Navigator Arm
1 of 1
Experimental Treatment

337 Total Participants · 1 Treatment Group

Primary Treatment: Patient Navigator · No Placebo Group · N/A

Patient Navigator Arm
Experimental Group · 1 Intervention: Patient Navigator · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 to 24 months

Who is running the clinical trial?

University of CalgaryLead Sponsor
701 Previous Clinical Trials
492,554 Total Patients Enrolled
University of AlbertaOTHER
805 Previous Clinical Trials
369,296 Total Patients Enrolled
Alberta Health servicesOTHER
143 Previous Clinical Trials
305,197 Total Patients Enrolled
Susan Samuel, MD, MScPrincipal InvestigatorUniversity of Calgary
1 Previous Clinical Trials
400 Total Patients Enrolled
Gina Dimitropoulos, PhDPrincipal InvestigatorUniversity of Calgary
1 Previous Clinical Trials
117 Total Patients Enrolled
Andrew Mackie, MDPrincipal InvestigatorUniversity of Alberta
1 Previous Clinical Trials
36 Total Patients Enrolled

Eligibility Criteria

Age < 65 · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 24th, 2021

Last Reviewed: October 28th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
New York33.3%
How old are they?
18 - 65100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%